Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development

被引：2

作者：

Li, Xinghang ^{[1
]}

Zeng, Fengyuan ^{[1
]}

Yue, Rong ^{[1
]}

Ma, Danjing ^{[1
]}

Meng, Ziyan ^{[1
]}

Li, Qi ^{[1
]}

Zhang, Zhenxiao ^{[1
]}

Zhang, Haobo ^{[1
]}

Liao, Yuansheng ^{[1
]}

Liao, Yun ^{[1
]}

Jiang, Guorun ^{[1
]}

Zhao, Heng ^{[1
]}

Yu, Li ^{[1
]}

Li, Dandan ^{[1
]}

Zhang, Ying ^{[1
]}

Liu, Longding ^{[1
]}

Li, Qihan ^{[1
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming 650118, Peoples R China

来源：

VACCINES | 2024年 / 12卷 / 02期

基金：

中国国家自然科学基金;

关键词：

SARS-CoV-2; vaccine; sequential immunization; B-cell receptor; humoral immunity; B-CELL RECEPTOR; COVID-19; MECHANISMS; CLONING;

D O I：

10.3390/vaccines12020120

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Recent studies have indicated that sequentially administering SARS-CoV-2 vaccines can result in increased antibody and cellular immune responses. In this study, we compared homologous and heterologous immunization strategies following two doses of inactivated vaccines in a mouse model. Our research demonstrates that heterologous sequential immunization resulted in more immune responses displayed in the lymph node germinal center, which induced a greater number of antibody-secreting cells (ASCs), resulting in enhanced humoral and cellular immune responses and increased cross-protection against five variant strains. In further single B-cell analysis, the above findings were supported by the presence of unique B-cell receptor (BCR) repertoires and diversity in CDR3 sequence profiles elicited by a heterologous booster immunization strategy.

引用

页数：18

共 50 条

[1] Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Fanglei Zuo
Hassan Abolhassani
Likun Du
Antonio Piralla
Federico Bertoglio
Leire de Campos-Mata
Hui Wan
Maren Schubert
Irene Cassaniti
Yating Wang
Josè Camilla Sammartino
Rui Sun
Stelios Vlachiotis
Federica Bergami
Makiko Kumagai-Braesch
Juni Andréll
Zhaoxia Zhang
Yintong Xue
Esther Veronika Wenzel
Luigi Calzolai
Luca Varani
Nima Rezaei
Zahra Chavoshzadeh
Fausto Baldanti
Michael Hust
Lennart Hammarström
Harold Marcotte
Qiang Pan-Hammarström
Nature Communications, 13
[2] Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Zuo, Fanglei
Abolhassani, Hassan
Du, Likun
Piralla, Antonio
Bertoglio, Federico
de Campos-Mata, Leire
Wan, Hui
Schubert, Maren
Cassaniti, Irene
Wang, Yating
Sammartino, Jose Camilla
Sun, Rui
Vlachiotis, Stelios
Bergami, Federica
Kumagai-Braesch, Makiko
Andrell, Juni
Zhang, Zhaoxia
Xue, Yintong
Wenzel, Esther Veronika
Calzolai, Luigi
Varani, Luca
Rezaei, Nima
Chavoshzadeh, Zahra
Baldanti, Fausto
Hust, Michael
Hammarstrom, Lennart
Marcotte, Harold
Pan-Hammarstrom, Qiang
NATURE COMMUNICATIONS, 2022, 13 (01)
[3] SARS-CoV-2 Vaccine and Booster Immunization Response in Patients with Humoral Immunodeficiency
Barmettler, Sara
DiGiacomo, Daniel
Yang, Nancy
Lam, Tiffany
Naranbhai, Vivek
Dighe, Anand
Burke, Kristin
Farmer, Jocelyn
JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S98 - S99
[4] Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Mendez, Constanza
Penaloza, Hernan F.
Schultz, Barbara M.
Pina-Iturbe, Alejandro
Rios, Mariana
Moreno-Tapia, Daniela
Pereira-Sanchez, Patricia
Leighton, Diane
Orellana, Claudia
Covarrubias, Consuelo
Galvez, Nicolas M. S.
Soto, Jorge A.
Duarte, Luisa F.
Rivera-Perez, Daniela
Vazquez, Yaneisi
Cabrera, Alex
Bustos, Sergio
Iturriaga, Carolina
Urzua, Marcela
Navarrete, Maria S.
Rojas, Alvaro
Fasce, Rodrigo A.
Fernandez, Jorge
Mora, Judith
Ramirez, Eugenio
Gaete-Argel, Aracelly
Acevedo, Monica
Valiente-Echeverria, Fernando
Soto-Rifo, Ricardo
Weiskopf, Daniela
Grifoni, Alba
Sette, Alessandro
Zeng, Gang
Meng, Weining
Gonzalez-Aramundiz, Jose V.
Gonzalez, Pablo A.
Abarca, Katia
Melo-Gonzalez, Felipe
Bueno, Susan M.
Kalergis, Alexis M.
EBIOMEDICINE, 2023, 91
[5] Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?
Kara, Ertan
Tanir, Ferdi
Demirhindi, Hakan
Mete, Burak
Kibar, Filiz
Cetiner, Salih
Candevir, Aslihan
Inaltekin, Ayse
MIKROBIYOLOJI BULTENI, 2022, 56 (03): : 566 - 573
[6] Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity
Zheng, Xiaotong
Yang, Rong
Zhao, Yuxiu
Zhang, Yadan
Yuan, Guangying
Li, Weidong
Xiao, Zhuangzhuang
Dong, Xiaofei
Ma, Meng
Guo, Yancen
Wang, Wei
Zhao, Xue
Yang, Hongqiang
Qiu, Shaoting
Peng, Zheng
Liu, Ankang
Yu, Shouzhi
Zhang, Yuntao
VIROLOGY, 2024, 594
[7] Development of an inactivated vaccine candidate for SARS-CoV-2
Gao, Qiang
Bao, Linlin
Mao, Haiyan
Wang, Lin
Xu, Kangwei
Yang, Minnan
Li, Yajing
Zhu, Ling
Wang, Nan
Lv, Zhe
Gao, Hong
Ge, Xiaoqin
Kan, Biao
Hu, Yaling
Liu, Jiangning
Cai, Fang
Jiang, Deyu
Yin, Yanhui
Qin, Chengfeng
Li, Jing
Gong, Xuejie
Lou, Xiuyu
Shi, Wen
Wu, Dongdong
Zhang, Hengming
Zhu, Lang
Deng, Wei
Li, Yurong
Lu, Jinxing
Li, Changgui
Wang, Xiangxi
Yin, Weidong
Zhang, Yanjun
Qin, Chuan
SCIENCE, 2020, 369 (6499) : 77 - +
[8] Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series
Sherman, Amy C.
van Haren, Simon D.
Borberg, Ella
Swank, Zoe
Aleissa, Muneerah
Tong, Alexandra
Rooks, Rebecca
Kanwal, Urwah
Levine, Hannah
Yates, Bridget
Izaguirre, Natalie
Ryff, Kevin
Thomas, Sanya
Parisi, Lindsey
Li, Xiaofang
Walt, David R.
Levy, Ofer
Walsh, Stephen R.
Issa, Nicolas C.
Baden, Lindsey R.
VACCINE, 2024, 42 (22)
[9] Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
Altmann, Daniel M.
Boyton, Rosemary J.
LANCET RESPIRATORY MEDICINE, 2021, 9 (12): : 1356 - 1358
[10] Inactivated vaccine for SARS-CoV-2
Emma Risson
Nature Reviews Immunology, 2020, 20 : 353 - 353

← 1 2 3 4 5 →